Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
1,351
-57
-4% -$14.4K 0.06% 84
2026
Q1
$341K Hold
1,408
0.06% 89
2025
Q4
$417K Buy
1,408
+48
+4% +$14.4K 0.08% 72
2025
Q3
$384K Buy
1,360
+50
+4% +$13.1K 0.08% 70
2025
Q2
$386K Buy
1,310
+1
+0.1% +$258 0.08% 72
2025
Q1
$326K Sell
1,309
-16
-1% -$3.91K 0.07% 72
2024
Q4
$291K Sell
1,325
-263
-17% -$58.6K 0.06% 83
2024
Q3
$351K Hold
1,588
0.07% 82
2024
Q2
$275K Buy
1,588
+12
+0.8% +$2.08K 0.06% 90
2024
Q1
$301K Buy
1,576
+116
+8% +$21.2K 0.07% 86
2023
Q4
$239K Buy
+1,460
New +$221K 0.06% 96
2022
Q4
Sell
-1,962
Closed -$233K 102
2022
Q3
$233K Hold
1,962
0.08% 91
2022
Q2
$277K Hold
1,962
0.09% 83
2022
Q1
$255K Sell
1,962
-368
-16% -$48K 0.07% 91
2021
Q4
$311K Buy
+2,330
New +$292K 0.08% 79

Other funds holding IBM

M. Kulyk & Associates's IBM Position: Q2 2026 in Review

M. Kulyk & Associates reduced its IBM (IBM) stake by 4% in Q2 2026, selling an estimated $14.4K and leaving 1,351 shares worth $380K. The position accounts for 0.06% of the portfolio, ranked #84.

M. Kulyk & Associates first reported a position in IBM in Q4 2021 and has held it in 15 quarters since. The position peaked at $417K in Q4 2025. 3,629 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • M. Kulyk & Associates held 1,351 shares of IBM worth $380K as of Q2 2026.
  • M. Kulyk & Associates sold 57 IBM shares in Q2 2026, an estimated $14.4K.
  • IBM made up 0.06% of M. Kulyk & Associates's portfolio in Q2 2026, its #84 holding.
  • M. Kulyk & Associates first reported a position in IBM in Q4 2021 and has held it in 15 quarters since.
  • M. Kulyk & Associates's IBM position peaked at $417K in Q4 2025.
  • 3,629 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on M. Kulyk & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.